Novo Holdings A/S sold MPLT
October 28, 2025 · Form 4 insider transaction
Novo Holdings A/S sold 26,191,207 shares of MapLight Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
26,191,207
Price
$0.00
Total value
N/A
InsiderNovo Holdings A/S
Role10% owner
SecuritySeries C Preferred Stock
Transaction codeC: Conversion of a derivative
Transaction dateOctober 28, 2025
Filing dateOctober 30, 2025
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Series C Preferred Stock and Series D Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.